About MNF
About Maternal and Newborn Fund
Improving maternal nutrition is one of the smartest, most cost-effective investments in global health.
— World Health Organization
Established as a Swiss non-profit association headquartered in Geneva, the Maternal and Newborn Fund (MNF) combines philanthropic capital with catalytic financing tools to deliver large-scale, evidence-based solutions that protect mothers and improve newborn outcomes. Backed by a trusted network of technical partners and multilateral agencies, MNF tackles the most urgent and preventable causes of maternal and newborn mortality through cost-effective interventions that are embedded in national systems and strengthened through global partnerships.
At its core is BirthStrong, the flagship program set to distribute over 915 million Multiple Micronutrient Supplements (MMS). This bold, scalable initiative transforms the most vulnerable phase of life, pregnancy, into a safer and more empowered experience, helping to prevent anaemia, reduce adverse outcomes, and give newborns a stronger start to life.
MNF is also a core member of the global MMS coalition, alongside Kirk Humanitarian, the Children’s Investment Fund Foundation (CIFF), the Gates Foundation, and other leading partners. Together, the coalition is advancing a global roadmap to reach 260 million women in 63 crisis-affected countries by 2030. By aligning its financing and large-scale delivery model with this collective effort, MNF helps ensure that resources are mobilised efficiently and life-saving nutrition reaches those who need it most.
MNF combines blended finance, public-private partnerships, and local system strengthening to create lasting, measurable impact in fragile contexts
Our Vision
A world where every pregnancy is nourished, and every newborn begins life with the chance to thrive. Through focused investment in maternal nutrition and resilient health systems, MNF protects mothers and unlocks brighter futures for generations to come.
Our Mission & Objectives
To drive sustainable improvements in maternal and newborn outcomes by:
Fund Raising
Mobilising $3 billion in catalytic capital to drive sustainable outcomes
Impact
Reaching 260 million pregnant women with evidence-based nutritional support
Access
Distributing over 915 million MMS tablets across high-need countries
Mission
Supporting local manufacturing of MMS to reduce costs and create jobs
Provision
Strengthening national health systems and public sector integration
Development
Develop financing models for lasting nutrition and health resilience
Strategic Impact Committee
To guide program excellence and ensure that delivery remains evidence-based, locally grounded, and globally credible, MNF is advised by a high-level Strategic Impact Committee.
This Committee brings together distinguished professionals with extensive experience in:
- Global maternal and child health
- UN agency-led nutrition programming in Africa
- Pharmaceutical innovation and micronutrient product development
- Humanitarian response and large-scale field implementation
- Innovative financing and global philanthropic strategy
The Strategic Impact Committee provides expert oversight across programme design, delivery standards, partnership frameworks, production systems, and capital mobilisation—ensuring MNF delivers meaningful and measurable impact in the world’s most fragile and underserved contexts.
